This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A second look: Discussing Nerandomilast in IPF following the publication in NEJM

Ticker(s): BOEHRINGER INGELHEIM

Who's the expert?

Institution: Huntington Beach Internal Medicine Group

  • Assistant Clinical Professor at UC Irvine School of Medicine and Board Certified Pulmonologist at Huntington Beach Internal Medicine Group
  • Manages 250+ patients with COPD and 80 patients with emphysema. Has placed the Zephyr and Spiration valve for patients.
  • Research interest in the areas of asthma, emphysema, and diseases of the chest.
  • Manages 60 patients per month for sleep apnea.

Interview Goal
Discuss the publication of phase 3 data of nerandomilast and how it may fit into the treatment algorithm

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.